In terms of research and diagnostics, the most important news that emerged during the recent ICML conference is the role that "liquid biopsy" plays in the detection of tumor specific DNA in the patient's peripheral blood. The early diagnosis of the reappearance of the tumor when there are still no symptoms and the disease is not yet aggressive allows us to adopt the most effective treatment well in advance.